In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 178 for your search:
Drug:  cyclosporine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: SMD/ATG-CSA/2002, NCT00488436

2.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684

3.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 50
Sponsor:
Protocol IDs: FHCRC-122, NCI-V83-0098

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 to 50
Sponsor:
Protocol IDs: FHCRC-127, NCI-V83-0362

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO268, NCI-V84-0067

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 to 60
Sponsor: Other
Protocol IDs: OSU-84HO140, NCI-V84-0071

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO270, NCI-V84-0070

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI
Protocol IDs: CCG-213

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 to 55
Sponsor:
Protocol IDs: OSU-84HO226, NCI-V85-0224

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 55 and under
Sponsor:
Protocol IDs: FHCRC-431, NCI-V89-0262

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 51
Sponsor: NCI
Protocol IDs: SWOG-8612

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI
Protocol IDs: SWOG-8706

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: SWOG-9032

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 6 months to 21 years
Sponsor: NCI
Protocol IDs: CCG-1921

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: SWOG-9126

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000258113, U10CA021115, E1900, ECOG-1900, NCT00049517

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1813.00, NCI-2009-01532, P01CA078902, P30CA015704, FHCRC-1813.00, 5666, NCT00075478

21.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2003.333, NCT00133887

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1992.00, NCI-2010-00737, P01CA078902, K23HL084054, P01CA018029, P01HL036444, FHCRC-1992.00, 6170, NHLBI-K23-HL084054-01A1, NCT00322101

23.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CCLG-LCH-2006-02, EU-20619, UKCCSG-HLH-2004, EUDRACT-2005-002187-28, NCT00334672

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AAML0531, COG-AAML0531, CDR0000487497, NCT00372593

25.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CTRU-PICCOLO-MO-05-7289, EUDRACT-2005-003492-20, CTAAC-CTRU-PICCOLO-MO-05-7289, AMGEN-CTRU-PICCOLO-MO-05-7289, EU-20647, NCT00389870
1     
New Search